Reproducibility of nasal allergen challenge responses in adults with allergic rhinitis
Charles T Pantin,1 Thomas Southworth,1 Kristiane Wetzel,2 Dave Singh1 1Medicines Evaluation Unit, Manchester Academic Health Science Centre, Manchester University NHS Foundation Trust, University of Manchester, Manchester, UK; 2Translational Medicine and Clinical Pharmacology, Boehringer Ingelheim P...
Guardado en:
Autores principales: | Pantin CT, Southworth T, Wetzel K, Singh D |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7563137f17b84e78bd0757d64d18ac1b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Rationally designed nanocarriers for intranasal therapy of allergic rhinitis: influence of carrier type on in vivo nasal deposition
por: Sallam MA, et al.
Publicado: (2016) -
EFFICIENCY OF PHARMACOTHERAPY IN ALLERGIC RHINITIS, AS EVALUATED BY DECREASED CONCENTRATIONS OF FREE HEMOGLOBIN IN NASAL SECRETIONS
por: A. A. Mokronosova, et al.
Publicado: (2014) -
Clinical Relevance and Advantages of Intradermal Test Results in 371 Patients with Allergic Rhinitis, Asthma and/or Otitis Media with Effusion
por: David S. Hurst, et al.
Publicado: (2021) -
ALLERGEN-SPECIFIC IMMUNOTHERAPY: VACCINES FOR ALLERGIC DISEASES
por: A. S. Fedorov, et al.
Publicado: (2015) -
EOSINOPHILIC CATIONIC PROTEIN AS A MARKER OF ALLERGIC INFLAMMATION OF NASAL MUCOSA
por: M. A. Mokronosova, et al.
Publicado: (2014)